Enhanced bone regeneration associated with decreased apoptosis in mice with partial HIF-1alpha deficiency
about
Hypoxia and TGF-beta drive breast cancer bone metastases through parallel signaling pathways in tumor cells and the bone microenvironment.Mustn1 is expressed during chondrogenesis and is necessary for chondrocyte proliferation and differentiation in vitroAngiogenesis in bone regeneration.Modulation of Wnt signaling influences fracture repairA central role for hypoxic signaling in cartilage, bone, and hematopoiesis.Silencing of Mustn1 inhibits myogenic fusion and differentiation.Genetic association of angiogenesis- and hypoxia-related gene polymorphisms with osteonecrosis of the femoral headInactivation of Vhl in osteochondral progenitor cells causes high bone mass phenotype and protects against age-related bone loss in adult mice.Hypoxia-inducible factor regulates osteoclast-mediated bone resorption: role of angiopoietin-like 4The convergence of fracture repair and stem cells: interplay of genes, aging, environmental factors and disease.Identification and Characterization of a Synthetic Osteogenic Peptide.Multifaceted signaling regulators of chondrogenesis: Implications in cartilage regeneration and tissue engineeringβ-arrestin-selective G protein-coupled receptor agonists engender unique biological efficacy in vivoEffects of IL-1 receptor-associated kinase-4 gene silencing on human osteoblast-like cells.Effect of age on vascularization during fracture repair.TNF-alpha mediates diabetes-enhanced chondrocyte apoptosis during fracture healing and stimulates chondrocyte apoptosis through FOXO1.Prolyl hydroxylase inhibitors increase neoangiogenesis and callus formation following femur fracture in mice.
P2860
Q21142766-46B7F419-F140-4E1F-84A4-56A52138204AQ28586032-5AA74EA7-45AC-46EC-84BF-A72416540096Q30467055-94362D89-984E-46FD-A400-7D0EB5CFDEB8Q33523084-90659AE9-26A5-422D-941C-2230F7C94C98Q33576042-521DA47B-9B07-41E6-9EFC-78873E01FB92Q33840459-85E3ADCF-3DD1-4C14-A6C9-F55501E56F26Q33879871-9699F5C0-12A7-4868-B833-3FB2A635C7F0Q33951258-132C6382-4B4A-4581-A0FF-393F264D3465Q34352831-9001B595-A058-4024-9D71-E0396D86B49DQ35683050-6DCACB10-EA60-460E-9F22-85514AE0B4F3Q36236833-B0CCF1E5-90A5-4618-860F-99EC3F7BA2FCQ36514312-4AB2E669-13F4-477B-A4F3-F29FCDDF080EQ36932538-D455B4CA-A271-44B4-AFE3-DEDB276E2388Q39346223-DA5D46D7-61CD-4DD8-ADC3-47D9F70E5AF3Q39836942-1EADE09F-C30B-4834-A39E-F686E8BB33F7Q42274273-6823392E-23AC-4672-913F-87D4AB5F5A51Q42592249-A21BD74B-F17E-4D4D-AB8F-5D1BE18A7677
P2860
Enhanced bone regeneration associated with decreased apoptosis in mice with partial HIF-1alpha deficiency
description
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2007
@ast
im März 2007 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2007/03/01)
@sk
vědecký článek publikovaný v roce 2007
@cs
wetenschappelijk artikel (gepubliceerd op 2007/03/01)
@nl
наукова стаття, опублікована в березні 2007
@uk
مقالة علمية (نشرت في مارس 2007)
@ar
name
Enhanced bone regeneration ass ...... partial HIF-1alpha deficiency
@ast
Enhanced bone regeneration ass ...... partial HIF-1alpha deficiency
@en
Enhanced bone regeneration ass ...... partial HIF-1alpha deficiency
@nl
type
label
Enhanced bone regeneration ass ...... partial HIF-1alpha deficiency
@ast
Enhanced bone regeneration ass ...... partial HIF-1alpha deficiency
@en
Enhanced bone regeneration ass ...... partial HIF-1alpha deficiency
@nl
prefLabel
Enhanced bone regeneration ass ...... partial HIF-1alpha deficiency
@ast
Enhanced bone regeneration ass ...... partial HIF-1alpha deficiency
@en
Enhanced bone regeneration ass ...... partial HIF-1alpha deficiency
@nl
P2093
P2860
P356
P1476
Enhanced bone regeneration ass ...... partial HIF-1alpha deficiency
@en
P2093
David E. Komatsu
Marta Bosch-Marce
Michael Hadjiargyrou
P2860
P304
P356
10.1359/JBMR.061207
P577
2007-03-01T00:00:00Z